Mission indicators

in page functions

Five mission indicators reflect our overall aspiration for the 2016-2020 period

Children immunised

What we measure: the number of children immunised with the last recommended dose of a Gavi-supported vaccine delivered through routine systems.a People immunised through campaigns and supplementary immunisation activities are not included.

Future deaths prevented

What we measure: the number of future deaths prevented as a result of vaccination with Gavi-funded vaccines in the countries we support.

Under-five mortality rate

What we measure: the average probability of a child born in any of the Gavi-supported countries dying before they reach the age of five.b  

Future disability-adjusted life years averted

What we measure: the number of future disability-adjusted life years (DALYs) averted as a result of vaccination with Gavi-supported vaccines. DALYs measure the number of healthy years lost due to disability or premature death.

Vaccines sustained after Gavi support ends

What we measure: the percentage of countries that continue to deliver all recommended vaccines included in their routine programmes after they transition out of Gavi financing. This indicator covers all vaccines recommended by national authorities for routine immunisation, not only those supported by Gavi.

Disease dashboard

Our goal is to reduce the overall disease burden in the countries we support. Therefore we also monitor the proportion of Gavi-supported countries with low prevalence of three infectious diseases – hepatitis B, rotavirus diarrhoea, and measles – as part of a “disease dashboard”.

All three diseases can be prevented by Gavi-supported vaccines.

In the absence of reliable data for a large number of Gavi-supported countries, we are currently only able to monitor disease trends for some countries. We remain committed to measuring our impact on countries’ disease burden, and will continue to assess the availability and quality of this data.

The Alliance is discussing what, if any, additional contextual information could be used to supplement the dashboard indicators.

a To ensure that we do not double-count children who receive more than one vaccine, we only take into account the Gavi-supported vaccine with the highest coverage level in each country.
b Projection.


US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here